People living with irritable bowel syndrome (IBS) may face increased health risks from commonly prescribed medications, according to recent research.

Study Links IBS Drugs to Mortality

A study published in Communications Medicine suggests that antidepressants and anti-diarrheal drugs may be associated with a higher mortality risk in IBS patients. Researchers analyzed data from over 600,000 individuals across 106 U.S. healthcare organizations, observing trends over a period of up to 15 years.

Antidepressants and IBS Subtypes

The study found a correlation between antidepressant use and increased mortality across all IBS subtypes. However, the specific causes of death linked to antidepressant use remain unclear.

Anti-Diarrheals and IBS-D

Specifically, anti-diarrheal medications like diphenoxylate and loperamide were linked to an increased risk of mortality in patients diagnosed with IBS-D (IBS with diarrhea).

Expert Recommendations & Cautions

Pharmacist Reshma Kapadia Patel and gastroenterologist David Kahana emphasize that these findings are concerning but do not necessitate immediately stopping prescribed medications. They recommend regular reviews with healthcare providers to evaluate the effectiveness and safety of ongoing treatments, particularly for long-term use.

Potential Risks of Medication

Experts suggest potential mechanisms behind the observed risks, including disruptions to gut-brain communication, heart function, and electrolyte balance. It’s important to note that the study is observational and does not prove a direct causal link.

Focus on Non-Pharmacological Treatments

Both Patel and Kahana highlight the importance of exploring non-pharmacological approaches to IBS management. These include dietary modifications, the use of probiotics, and lifestyle changes.

Dietary and Lifestyle Adjustments

IBS is strongly connected to diet, gut-brain interactions, and lifestyle. Avoiding trigger foods – such as dairy, processed foods, and spicy foods – can significantly alleviate symptoms. Supplements like fiber and digestive enzymes may also support digestive health.

The overall goal, according to the experts, is to prioritize the safest and most effective strategies for the long-term management of IBS, rather than avoiding treatment altogether.